$2.61 -0.08 (%) Vivus Inc - NASDAQ

Feb. 27, 2015 | 04:00 PM

Partner Headlines

  1. JPM Securities Picks Through Biotech News For Winners

    Benzinga | Feb. 25, 2015 | 12:41PM EST
  2. Wednesday's #PreMarket Movers: Hewlett-Packard, Dreamworks Animation Trending Lower

    Benzinga | Feb. 25, 2015 | 09:22AM EST
  3. UPDATE: VIVUS Posts Q4 Loss

    Benzinga | Feb. 24, 2015 | 17:21PM EST
  4. Earnings Scheduled For February 24, 2015

    Benzinga | Feb. 24, 2015 | 04:57AM EST
  5. 5-year lows: Vivus, Synta Pharmaceuticals Inc, MVC Capital Inc, and Kemet Corp.

    GuruFocus | Feb. 8, 2015 | 20:58PM EST
  6. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 23, 2015 | 08:15AM EST
  7. Mid-Morning Market Update: Markets Mixed; UnitedHealth Profit Tops Expectations

    Benzinga | Jan. 21, 2015 | 10:42AM EST
  8. 5 Obesity Stocks Investors Are Watching

    Benzinga | Jan. 14, 2015 | 13:55PM EST
  9. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 4

    Benzinga | Jan. 13, 2015 | 11:34AM EST
  10. Stocks Hitting 52-Week Lows

    Benzinga | Dec. 30, 2014 | 10:31AM EST
  11. 4 Potential Blockbuster Drugs The FDA Just Approved

    IBD | Dec. 26, 2014 | 12:35PM EST
  12. Orexigen Therapeutics Gains On Diet Pill Nod From European Committee

    Benzinga | Dec. 19, 2014 | 14:09PM EST
  13. Pharmaceutical Stocks In Play Following Merck/Cubist Deal

    Benzinga | Dec. 8, 2014 | 09:09AM EST
  14. What's Driving Orexigen Therapeutics Higher?

    Benzinga | Nov. 13, 2014 | 12:10PM EST
  15. Earnings Scheduled For November 5, 2014

    Benzinga | Nov. 5, 2014 | 05:05AM EST
  16. 3 Pharma Companies Fighting Obesity

    Benzinga | Oct. 30, 2014 | 14:00PM EST
  17. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga | Oct. 20, 2014 | 16:58PM EST
  18. Endo Buyout Of Auxilium Joins Two Changing Firms

    IBD | Oct. 9, 2014 | 19:00PM EST
  19. Vivus, Inc. Opens Sharply Higher On ED Drug Marketing Approval

    Benzinga | Sep. 18, 2014 | 09:55AM EST
  20. Morning Market Movers

    Benzinga | Sep. 18, 2014 | 09:46AM EST
  21. Benzinga's Top #PreMarket Gainers

    Benzinga | Sep. 18, 2014 | 08:05AM EST
  22. US Stock Futures Up Ahead Of Jobless Claims, Housing Starts Data

    Benzinga | Sep. 18, 2014 | 07:10AM EST
  23. FDA delays Orexigen drug

    IBD | Jun. 11, 2014 | 18:57PM EST
  24. Orexigen Obesity Drug Decision Delayed By FDA

    IBD | Jun. 11, 2014 | 11:55AM EST
  25. Orexigen Shares Plummet Following FDA Decision; Competition Gets A Bump

    Benzinga | Jun. 11, 2014 | 11:24AM EST
  26. Is Vivus About To Get Squeezed?

    Benzinga | Jun. 9, 2014 | 14:54PM EST
  27. Benzinga's Top #PreMarket Gainers

    Benzinga | May. 6, 2014 | 08:06AM EST
  28. Shares of Vivus Fall +10% Following Piper Jaffray's Downgrade

    Benzinga | Apr. 3, 2014 | 13:03PM EST
  29. Mid-Day Market Update: US Stocks Fall; Google Shares Rise After Stock Split

    Benzinga | Apr. 3, 2014 | 12:41PM EST
  30. Mid-Morning Market Update: Markets Mostly Flat; Greenbrier Results Beat Estimates

    Benzinga | Apr. 3, 2014 | 10:43AM EST
  31. Morning Market Losers

    Benzinga | Apr. 3, 2014 | 09:49AM EST
  32. Benzinga's Top #PreMarket Losers

    Benzinga | Apr. 3, 2014 | 08:29AM EST
  33. Benzinga's Top Downgrades

    Benzinga | Apr. 3, 2014 | 07:47AM EST
  34. Biotech Auxilium Boosts Position In Men's Health Care

    IBD | Apr. 1, 2014 | 17:31PM EST
  35. Weekly Three-Year Low Highlight: VVUS, RALY, WILN, COVS

    GuruFocus | Mar. 25, 2014 | 11:50AM EST
  36. Vivus Announces Review Article Summarizing Cardiovascular Benefit-Risk Profile of Qsymia

    Benzinga | Mar. 25, 2014 | 07:50AM EST
  37. Auxilium Q4 Beats Estimates, But Guidance Cautious

    IBD | Feb. 28, 2014 | 10:42AM EST
  38. Mid-Afternoon Market Update: Markets Turn Red as Tesla Continues to Rip Higher

    Benzinga | Feb. 25, 2014 | 15:51PM EST
  39. Mid-Day Market Update: US Stocks Mostly Flat; Office Depot Shares Decline On Q4 Results

    Benzinga | Feb. 25, 2014 | 13:07PM EST
  40. Mid-Morning Market Update: Markets Fall; Home Depot Profit Beats Estimates

    Benzinga | Feb. 25, 2014 | 11:44AM EST
  41. UPDATE: Vivus Down Nearly 12% After JP Morgan Downgrade on Lackluster Qsymia News

    Benzinga | Feb. 25, 2014 | 11:30AM EST
  42. Stocks Hitting 52-Week Lows

    Benzinga | Feb. 25, 2014 | 10:21AM EST
  43. Morning Movers for Feb. 25, 2014: IMUC, MSO, ZU, CARA, VSI, TSLA, XOMA, BCRX Moving Higher, RP, ODP, VVUS, AINV, MGIC, ALSN Lower

    Benzinga | Feb. 25, 2014 | 09:41AM EST
  44. Benzinga's Top #PreMarket Losers

    Benzinga | Feb. 25, 2014 | 08:14AM EST
  45. UPDATE: Bank of America Downgrades Vivus as Partnering Prospects Weaken

    Benzinga | Feb. 25, 2014 | 08:12AM EST
  46. US Stock Futures Slip Ahead Of Economic Data

    Benzinga | Feb. 25, 2014 | 07:22AM EST
  47. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 14, 2014 | 08:09AM EST
  48. The Top Five Drug Launches Of 2013

    IBD | Dec. 31, 2013 | 13:42PM EST
  49. New ED Drug: Analysis of Vivus’s Prospects

    YCharts | Dec. 23, 2013 | 14:09PM EST
  50. VIVUS Announces License and Commercialization Agreement With Sanofi for Avanafil in Africa, Middle East, Turkey and CIS/Russia

    Benzinga | Dec. 12, 2013 | 07:01AM EST
Trading Center